BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/18/2022 7:25:42 AM | Browse: 311 | Download: 702
 |
Received |
|
2021-09-04 23:53 |
|
Peer-Review Started |
|
2021-09-04 23:53 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-11-08 03:45 |
|
Revised |
|
2021-11-19 18:47 |
|
Second Decision |
|
2022-07-08 02:52 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-07-11 19:16 |
|
Articles in Press |
|
2022-07-11 19:16 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-08-09 12:50 |
|
Publish the Manuscript Online |
|
2022-08-18 07:25 |
| ISSN |
2220-3206 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Psychiatry |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ping-Tao Tseng, Mu-Hong Chen and Chih-Sung Liang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Chih-Sung Liang, MD, Assistant Professor, Attending Doctor, Department of Psychiatry, Beitou Branch, Tri-Service General Hospital, National Defense Medical Center, No. 60 Xinmin Road, Beitou District, Taipei 112, Taiwan. lcsyfw@gmail.com |
| Key Words |
Treatment-resistant schizophrenia; Clozapine; Clozapine-resistant schizophrenia; Ultra-resistant schizophrenia; Ultra-treatment-resistant schizophrenia; Super-refractory schizophrenia |
| Core Tip |
A diagnosis of clozapine-resistant schizophrenia (CRS) is made after administering an adequate trial of clozapine and excluding “pseudo-resistance” in patients who have been diagnosed with treatment-resistant schizophrenia (TRS). Disentangling the differences between TRS and CRS is important point for studies addressing treatment strategies for patients with CRS. |
| Publish Date |
2022-08-18 07:25 |
| Citation |
Tseng PT, Chen MH, Liang CS. Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia. World J Psychiatry 2022; 12(8): 1102-1104 |
| URL |
https://www.wjgnet.com/2220-3206/full/v12/i8/1102.htm |
| DOI |
https://dx.doi.org/10.5498/wjp.v12.i8.1102 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
